434 related articles for article (PubMed ID: 21159377)
1. PEGylation of hyaluronic acid nanoparticles improves tumor targetability in vivo.
Choi KY; Min KH; Yoon HY; Kim K; Park JH; Kwon IC; Choi K; Jeong SY
Biomaterials; 2011 Mar; 32(7):1880-9. PubMed ID: 21159377
[TBL] [Abstract][Full Text] [Related]
2. Smart nanocarrier based on PEGylated hyaluronic acid for cancer therapy.
Choi KY; Yoon HY; Kim JH; Bae SM; Park RW; Kang YM; Kim IS; Kwon IC; Choi K; Jeong SY; Kim K; Park JH
ACS Nano; 2011 Nov; 5(11):8591-9. PubMed ID: 21967065
[TBL] [Abstract][Full Text] [Related]
3. Self-assembled hyaluronic acid nanoparticles for active tumor targeting.
Choi KY; Chung H; Min KH; Yoon HY; Kim K; Park JH; Kwon IC; Jeong SY
Biomaterials; 2010 Jan; 31(1):106-14. PubMed ID: 19783037
[TBL] [Abstract][Full Text] [Related]
4. Polyethylene glycol-conjugated hyaluronic acid-ceramide self-assembled nanoparticles for targeted delivery of doxorubicin.
Cho HJ; Yoon IS; Yoon HY; Koo H; Jin YJ; Ko SH; Shim JS; Kim K; Kwon IC; Kim DD
Biomaterials; 2012 Feb; 33(4):1190-200. PubMed ID: 22074664
[TBL] [Abstract][Full Text] [Related]
5. Stealth CD44-targeted hyaluronic acid supramolecular nanoassemblies for doxorubicin delivery: probing the effect of uncovalent pegylation degree on cellular uptake and blood long circulation.
Han X; Li Z; Sun J; Luo C; Li L; Liu Y; Du Y; Qiu S; Ai X; Wu C; Lian H; He Z
J Control Release; 2015 Jan; 197():29-40. PubMed ID: 25449802
[TBL] [Abstract][Full Text] [Related]
6. Robust PEGylated hyaluronic acid nanoparticles as the carrier of doxorubicin: mineralization and its effect on tumor targetability in vivo.
Han HS; Lee J; Kim HR; Chae SY; Kim M; Saravanakumar G; Yoon HY; You DG; Ko H; Kim K; Kwon IC; Park JC; Park JH
J Control Release; 2013 Jun; 168(2):105-14. PubMed ID: 23474029
[TBL] [Abstract][Full Text] [Related]
7. Development and characterization of hyaluronic acid decorated PLGA nanoparticles for delivery of 5-fluorouracil.
Yadav AK; Agarwal A; Rai G; Mishra P; Jain S; Mishra AK; Agrawal H; Agrawal GP
Drug Deliv; 2010 Nov; 17(8):561-72. PubMed ID: 20738221
[TBL] [Abstract][Full Text] [Related]
8. Hyaluronic acid coated poly(butyl cyanoacrylate) nanoparticles as anticancer drug carriers.
He M; Zhao Z; Yin L; Tang C; Yin C
Int J Pharm; 2009 May; 373(1-2):165-73. PubMed ID: 19429302
[TBL] [Abstract][Full Text] [Related]
9. Improved biological half-life and anti-tumor activity of TNF-related apoptosis-inducing ligand (TRAIL) using PEG-exposed nanoparticles.
Lim SM; Kim TH; Jiang HH; Park CW; Lee S; Chen X; Lee KC
Biomaterials; 2011 May; 32(13):3538-46. PubMed ID: 21306770
[TBL] [Abstract][Full Text] [Related]
10. Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin.
Yadav AK; Mishra P; Mishra AK; Mishra P; Jain S; Agrawal GP
Nanomedicine; 2007 Dec; 3(4):246-57. PubMed ID: 18068091
[TBL] [Abstract][Full Text] [Related]
11. Self-assembled nanoparticles based on hyaluronic acid-ceramide (HA-CE) and Pluronic® for tumor-targeted delivery of docetaxel.
Cho HJ; Yoon HY; Koo H; Ko SH; Shim JS; Lee JH; Kim K; Kwon IC; Kim DD
Biomaterials; 2011 Oct; 32(29):7181-90. PubMed ID: 21733572
[TBL] [Abstract][Full Text] [Related]
12. Ionic complex systems based on hyaluronic acid and PEGylated TNF-related apoptosis-inducing ligand for treatment of rheumatoid arthritis.
Kim YJ; Chae SY; Jin CH; Sivasubramanian M; Son S; Choi KY; Jo DG; Kim K; Chan Kwon I; Lee KC; Park JH
Biomaterials; 2010 Dec; 31(34):9057-64. PubMed ID: 20813405
[TBL] [Abstract][Full Text] [Related]
13. Hydrotropic hyaluronic acid conjugates: Synthesis, characterization, and implications as a carrier of paclitaxel.
Saravanakumar G; Choi KY; Yoon HY; Kim K; Park JH; Kwon IC; Park K
Int J Pharm; 2010 Jul; 394(1-2):154-61. PubMed ID: 20438818
[TBL] [Abstract][Full Text] [Related]
14. Theranostic nanoparticles based on PEGylated hyaluronic acid for the diagnosis, therapy and monitoring of colon cancer.
Choi KY; Jeon EJ; Yoon HY; Lee BS; Na JH; Min KH; Kim SY; Myung SJ; Lee S; Chen X; Kwon IC; Choi K; Jeong SY; Kim K; Park JH
Biomaterials; 2012 Sep; 33(26):6186-93. PubMed ID: 22687759
[TBL] [Abstract][Full Text] [Related]
15. Development and characterization of hyaluronic acid modified PLGA based nanoparticles for improved efficacy of cisplatin in solid tumor.
Alam N; Koul M; Mintoo MJ; Khare V; Gupta R; Rawat N; Sharma PR; Singh SK; Mondhe DM; Gupta PN
Biomed Pharmacother; 2017 Nov; 95():856-864. PubMed ID: 28903181
[TBL] [Abstract][Full Text] [Related]
16. In vitro macrophage uptake and in vivo biodistribution of long-circulation nanoparticles with poly(ethylene-glycol)-modified PLA (BAB type) triblock copolymer.
Shan X; Liu C; Yuan Y; Xu F; Tao X; Sheng Y; Zhou H
Colloids Surf B Biointerfaces; 2009 Sep; 72(2):303-11. PubMed ID: 19450955
[TBL] [Abstract][Full Text] [Related]
17. Hyaluronic acid nanoparticles for active targeting atherosclerosis.
Lee GY; Kim JH; Choi KY; Yoon HY; Kim K; Kwon IC; Choi K; Lee BH; Park JH; Kim IS
Biomaterials; 2015; 53():341-8. PubMed ID: 25890732
[TBL] [Abstract][Full Text] [Related]
18. Tumor-homing photosensitizer-conjugated glycol chitosan nanoparticles for synchronous photodynamic imaging and therapy based on cellular on/off system.
Lee SJ; Koo H; Lee DE; Min S; Lee S; Chen X; Choi Y; Leary JF; Park K; Jeong SY; Kwon IC; Kim K; Choi K
Biomaterials; 2011 Jun; 32(16):4021-9. PubMed ID: 21376388
[TBL] [Abstract][Full Text] [Related]
19. Multimodal tumor imaging by iron oxides and quantum dots formulated in poly (lactic acid)-D-alpha-tocopheryl polyethylene glycol 1000 succinate nanoparticles.
Tan YF; Chandrasekharan P; Maity D; Yong CX; Chuang KH; Zhao Y; Wang S; Ding J; Feng SS
Biomaterials; 2011 Apr; 32(11):2969-78. PubMed ID: 21257200
[TBL] [Abstract][Full Text] [Related]
20. Hyaluronic acid-modified hydrothermally synthesized iron oxide nanoparticles for targeted tumor MR imaging.
Li J; He Y; Sun W; Luo Y; Cai H; Pan Y; Shen M; Xia J; Shi X
Biomaterials; 2014 Apr; 35(11):3666-77. PubMed ID: 24462358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]